Keurig Dr Pepper, Inc $KDP Shares Acquired by Royal Bank of Canada

Key Points

• Royal Bank of Canada increased its stake in Keurig Dr Pepper by 19.7%, holding approximately 1.88 million shares valued at $64.43 million after acquiring additional shares in the first quarter.
• Other institutional investors, including Vanguard Group and JPMorgan Chase, have also significantly boosted their positions in Keurig Dr Pepper, indicating strong institutional interest in the company.
• Keurig Dr Pepper's latest earnings report showed a 6.1% year-over-year revenue increase, matching analysts' expectations with an earnings per share of $0.49.

Royal Bank of Canada grew its position in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 19.7% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,882,948 shares of the company's stock after acquiring an additional 309,830 shares during the period. Royal Bank of Canada owned about 0.14% of Keurig Dr Pepper worth $64,435,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. ST Germain D J Co. Inc. acquired a new position in shares of Keurig Dr Pepper in the first quarter worth about $27,000. WPG Advisers LLC acquired a new position in shares of Keurig Dr Pepper during the 1st quarter worth about $43,000. Continuum Advisory LLC raised its position in shares of Keurig Dr Pepper by 82.5% during the 1st quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock worth $46,000 after purchasing an additional 602 shares during the last quarter. Global Trust Asset Management LLC acquired a new position in shares of Keurig Dr Pepper during the 1st quarter worth about $48,000. Finally, LRI Investments LLC raised its position in shares of Keurig Dr Pepper by 65.6% during the 4th quarter. LRI Investments LLC now owns 1,527 shares of the company's stock worth $49,000 after purchasing an additional 605 shares during the last quarter. Institutional investors and hedge funds own 93.99% of the company's stock.

Insider Buying and Selling

In other Keurig Dr Pepper news, Director Robert James Gamgort sold 208,000 shares of the firm's stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $32.90, for a total value of $6,843,200.00. Following the completion of the transaction, the director owned 2,292,169 shares of the company's stock, valued at $75,412,360.10. This trade represents a 8.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Mary Beth Denooyer sold 12,000 shares of the firm's stock in a transaction that occurred on Thursday, July 17th. The shares were sold at an average price of $33.66, for a total transaction of $403,920.00. Following the completion of the transaction, the insider directly owned 82,511 shares of the company's stock, valued at $2,777,320.26. This represents a 12.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 459,601 shares of company stock valued at $15,228,872 in the last ninety days. 1.00% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

KDP has been the subject of several research analyst reports. Barclays upped their price target on shares of Keurig Dr Pepper from $37.00 to $39.00 and gave the stock an "overweight" rating in a research report on Monday, July 28th. Jefferies Financial Group set a $41.00 price target on shares of Keurig Dr Pepper in a research report on Monday, August 25th. Hsbc Global Res downgraded shares of Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 26th. UBS Group cut their price objective on shares of Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating for the company in a report on Wednesday, August 27th. Finally, HSBC reiterated a "hold" rating and issued a $30.00 price objective (down previously from $42.00) on shares of Keurig Dr Pepper in a report on Tuesday, August 26th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Keurig Dr Pepper has an average rating of "Moderate Buy" and an average price target of $38.38.

Keurig Dr Pepper Trading Down 0.1%

Shares of Keurig Dr Pepper stock traded down $0.04 during mid-day trading on Tuesday, hitting $27.60. The stock had a trading volume of 14,203,288 shares, compared to its average volume of 13,177,846. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56. The firm has a market cap of $37.49 billion, a P/E ratio of 24.64, a price-to-earnings-growth ratio of 1.57 and a beta of 0.47. The firm has a 50-day moving average of $32.83 and a two-hundred day moving average of $33.45. Keurig Dr Pepper, Inc has a 12-month low of $27.24 and a 12-month high of $38.28.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its quarterly earnings data on Thursday, July 24th. The company reported $0.49 earnings per share for the quarter, hitting analysts' consensus estimates of $0.49. The firm had revenue of $4.16 billion during the quarter, compared to analysts' expectations of $4.14 billion. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The firm's quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the company posted $0.45 EPS. Sell-side analysts forecast that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.